Gritstone bio, Inc.

GRTS · NASDAQ
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Activities
Net Income-$138-$120-$75-$105
Dep. & Amort.$8$7$6$7
Deferred Tax$2$0$1-$0
Stock-Based Comp.$12$13$11$7
Change in WC-$17-$25-$1-$5
Other Non-Cash$13$9$8$8
Operating Cash Flow-$122-$116-$51-$89
Investing Activities
PP&E Inv.-$5-$6-$5-$4
Net Acquisitions-$107$7$0-$69
Inv. Purchases-$26-$142-$200-$9
Inv. Sales/Matur.$133$135$87$78
Other Inv. Act.$107-$7-$0$69
Investing Cash Flow$102-$13-$119$66
Financing Activities
Debt Repay.$20$19-$0$0
Stock Issued$8$65$113$135
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$3-$1-$4$1
Financing Cash Flow$25$83$109$136
Forex Effect$0$0$0$0
Net Chg. in Cash$6-$46-$60$113
Supplemental Information
Beg. Cash$59$111$171$58
End Cash$65$65$111$171
Free Cash Flow-$126-$122-$56-$93